Agno Pharma is a leading global Contract Development and Manufacturing Organisation (CDMO) based in Bethlehem, Pennsylvania, USA. Established in 2004, the company specialises in providing comprehensive cGMP manufacturing solutions, focusing on the development and production of regulatory starting materials (RSMs), intermediates, and active pharmaceutical ingredients (APIs). Agno Pharma is particularly proficient in highly-potent and sterile APIs, as well as flow-based chemistry. The firm also excels in complex sterile drug product formulations, including injectable suspensions, emulsions, long-acting implants, and other implantable products.

Services include:
– Intermediates
– Fine Chemicals
– Machinery & Equipment
– Regulatory Services
– Containment
– APIs (Active Pharmaceutical Ingredients)
– Analytical Services

Agno Pharma aims to deliver the highest quality services and products through the synergistic merger of North American pharmaceutical technologies and China’s manufacturing capabilities. For further information, please visit agnopharma.com.